Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Molecular and Medicine Research Center, Department of Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.
Int J Biochem Cell Biol. 2019 Apr;109:76-81. doi: 10.1016/j.biocel.2019.01.015. Epub 2019 Feb 14.
Breast cancer is known as a most prevalent cancer and second deadly cancer, among women worldwide. Due to the high incidence rate of breast cancer and limitations of conventional therapy it seemed essential to look for new targets in cancer cells and directly target them such as target therapy on breast cancer stem cells. In this review we indicate some of therapeutic uses of cancer stem cells in breast cancer. Some strategies are targeting surface specific markers and activated signaling pathways in their microenvironment such as Notch, Hedgehog, Wnt/b-catenin, PI3K/Akt, NF-kB, BMP and TGF-β and their maintenance and drug resistance, using various miRNAs, enhancement of CSCs apoptosis, differentiation therapy, blocking epithelial to mesenchymal transition and using different natural compounds. Recent studies have shown that cancer stem cells play major roles in target therapy on breast cancer. The new manipulation approaches of cancer stem cells can be used as target therapy of breast cancer that were highlighted for immunotherapy of cancer.
乳腺癌是全球女性中最常见的癌症和第二大致命癌症。由于乳腺癌的发病率高和传统疗法的局限性,因此似乎有必要在癌细胞中寻找新的靶点,并直接针对这些靶点,例如针对乳腺癌干细胞的靶向治疗。在这篇综述中,我们指出了癌症干细胞在乳腺癌中的一些治疗用途。一些策略是针对其微环境中的表面特异性标志物和激活的信号通路,如 Notch、Hedgehog、Wnt/b-catenin、PI3K/Akt、NF-kB、BMP 和 TGF-β 及其维持和耐药性,使用各种 miRNA,增强 CSCs 凋亡,分化治疗,阻断上皮间质转化,并使用不同的天然化合物。最近的研究表明,癌症干细胞在乳腺癌的靶向治疗中起着重要作用。癌症干细胞的新操纵方法可以作为乳腺癌的靶向治疗,这为癌症的免疫治疗提供了亮点。